AcelRx Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$149.27 | $174.55 | 13.89% | 3 | $359.25B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.83 | $41.00 | 29.74% | 0 | $1.66B |
| ANIP | ANI Pharmaceuticals | Buy |
13
|
$67.25 | $69.75 | 18.96% | 1 | $1.38B |
| IRWD | Ironwood Pharmaceuticals | Buy |
14
|
$8.12 | $17.83 | 109.36% | 2 | $1.32B |
| COLL | Collegium Pharmaceutical | Outperform |
11
|
$37.51 | $37.75 | 6.64% | 1 | $1.23B |
| PCRX | Pacira BioSciences | Outperform |
16
|
$27.21 | $47.90 | 65.38% | 6 | $1.27B |
| HRTX | Heron Therapeutics | Buy |
7
|
$2.61 | $5.63 | 149.04% | 0 | $349.48M |
| AQST | Aquestive Therapeutics | Buy |
0
|
$3.52 | $6.33 | 155.68% | 0 | $298.61M |
| ZVRA | Zevra Therapeutics | Buy |
10
|
$4.81 | $19.50 | 284.62% | 1 | $253.06M |
| DRRX | DURECT | Outperform |
9
|
$1.16 | $6.75 | 481.90% | 2 | $36.00M |
| CPIX | Cumberland Pharmaceuticals | - |
0
|
$2.03 | $8.50 | -100.00% | 0 | $24.38M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
| TRVN | Trevena | Outperform |
2
|
$0.61 | $5.18 | 555.74% | 0 | $9.38M |
| BXRX | Baudax Bio | - |
0
|
$0.01 | $24.00 | -100.00% | 0 | $1.16M |
| DMK | DMK Pharmaceuticals | - |
8
|
$0.05 | $1.50 | -100.00% | 0 | $0.35M |